Title  | Date  | Price |
|---|
Cell therapy
Technologies, Markets and Companies
| Oct 2009 |
£2,745 |
Transdermal Drug Delivery
Technologies, Markets and Companies
| Oct 2009 |
£1,525 |
Recherches Développement En Biotechnologie
Etude de Portefeuille - Marché Français
| Oct 2009 |
£540 |
Pain Therapeutics
Drugs, Markets and Companies
| Oct 2009 |
£1,830 |
Cord Blood Stem Cells - A Global Market Overview
| Oct 2009 |
£2,635 |
Drug Delivery in Cancer
Technologies, Markets and Companies
| Oct 2009 |
£2,135 |
DNA sequencing
Technologies, Markets and Companies
| Oct 2009 |
£915 |
RNAi
Technologies, Markets and Companies
| Oct 2009 |
£1,830 |
Nitric oxide
Therapeutics, Markets and Companies
| Oct 2009 |
£1,705 |
Biotechnology in Spain
Biotechnology
| Sep 2009 |
£150 |
Biotechnology in Italy
Biotechnology
| Sep 2009 |
£150 |
Biotechnology in the Netherlands
Biotechnology
| Sep 2009 |
£150 |
Global Biotechnology
IBISWorld Industry Report
| Sep 2009 |
£455 |
Biotechnology in Germany
Biotechnology
| Sep 2009 |
£150 |
Biotechnology in the United States
Biotechnology
| Sep 2009 |
£150 |
Biotechnology in the United Kingdom
Biotechnology
| Sep 2009 |
£150 |
Future of White Biotechnology in China
| Sep 2009 |
£7,410 |
Global Biotechnology
Biotechnology
| Sep 2009 |
£150 |
Biotechnology in France
Biotechnology
| Sep 2009 |
£150 |
Biotechnology in Belgium
Biotechnology
| Sep 2009 |
£150 |
Biotechnology in Asia-Pacific
Biotechnology
| Sep 2009 |
£150 |
Biotechnology in Europe
Biotechnology
| Sep 2009 |
£150 |
Biotechnology in Canada
Biotechnology
| Sep 2009 |
£150 |
Biotechnology in China
Biotechnology
| Sep 2009 |
£150 |
Canadian Biotechnology Industry: Sector Report
| Aug 2009 |
£425 |
Indian Biotechnology Industry: Sector Report
| Aug 2009 |
£425 |
German Biotechnology Industry: Sector Report
| Aug 2009 |
£425 |
Chinese Biotechnology Industry: Sector Report
| Aug 2009 |
£425 |
France Biotechnology Industry: Sector Report
| Aug 2009 |
£425 |
Japanese Biotechnology Industry: Sector Report
| Aug 2009 |
£425 |
UK Biotechnology Industry: Sector Report
| Aug 2009 |
£425 |
US Biotechnology Industry: Sector Report
| Aug 2009 |
£425 |
Australian Biotechnology Industry: Sector Report
| Aug 2009 |
£425 |
Biotechnological Innovations In The Pharmaceutical Industry in Poland 2009
Development forecasts for biotechnology sector for 2009-2011
| Aug 2009 |
£1,830 |
The Global Biopharmaceuticals Industry Report
| Aug 2009 |
£950 |
The Global Biotechnology (Pharmaceuticals) Report
| Aug 2009 |
£950 |
World Market for Biosimilars and the Potential for US Follow-on Biologics, The
| Aug 2009 |
£2,255 |
Johnson & Johnson: Pipeline, Products, Performance, Potential
| Aug 2009 |
£595 |
Asia Pacific Biotechnology Market (2008-2012)
| Aug 2009 |
£975 |
The Worldwide Biochips & Equipments Market
Biochips Business Roadmap:
Technology Update, Market, Business Trends and Directions
| Jul 2009 |
£800 |
U.S. Bioethanol & Cellulosic Ethanol Market & Future Direction
| Jul 2009 |
£1,005 |
Biotechgate Company Database
A comprehensive life sciences information source
| Jul 2009 |
£1,095 |
Canadian Biotechnology Sector: Industry Profile
| Jun 2009 |
£365 |
Indian Biotechnology Sector: Industry Profile
| Jun 2009 |
£365 |
Biosimilars Series: Forecast Analysis
| Jun 2009 |
£6,950 |
Chinese Biotechnology Sector: Industry Profile
| Jun 2009 |
£365 |
Biotech Exit Strategies: Delivering value to investors in a challenging funding market
| Jun 2009 |
£2,340 |
Ceapro Inc. - Financial and Strategic Analysis Review
| Jun 2009 |
£77 |
Forecast Insight: Inflammatory Bowel Disease
New Product Launches Sustain Long-Term Market Growth
| Jun 2009 |
£9,270 |
Stem Cell Markets
| Jun 2009 |
£2,105 |
Global Medical Imaging Equipment Market 2008-2012
| Jun 2009 |
£610 |
US Biotechnology Sector: Industry Profile
| Jun 2009 |
£365 |
UK Biotechnology Sector: Industry Profile
| Jun 2009 |
£365 |
US Stem Cell Market Analysis
| May 2009 |
£490 |
Cell Culture: The World Market for Media, Sera and Reagents
2nd Edition
| May 2009 |
£2,435 |
A Quick Guide to Biotechnology and Healthcare in the Middle East
| Apr 2009 |
£180 |
Biosimilars and Follow-On Biologics Report
The Global Outlook 2009-2024
| Apr 2009 |
£1,499 |
Biosimilars
Problems, Prospects and Projections
| Apr 2009 |
£205 |
Companion Biomarkers in Drug Development
| Apr 2009 |
£2,105 |
Delving into Stem Cell Research and its Potential
| Apr 2009 |
£305 |
Canada's Biotechnology Industry: Porter's Five Forces Strategy Analysis
| Apr 2009 |
£150 |
Japan's Biotechnology Industry: Porter's Five Forces Strategy Analysis
| Apr 2009 |
£150 |
United States Biotechnology Industry: Porter's Five Forces Strategy Analysis
| Apr 2009 |
£150 |
Success Rates in Biotech
Going The Wrong Way
| Mar 2009 |
£895 |
Biotechnology in the US
IBISWorld Industry Report
| Mar 2009 |
£395 |
The Future of Biobanks: Regulation, ethics, investment and the humanization of drug discovery
Healthcare
| Mar 2009 |
£2,340 |
Strategic Analysis of U.S. MicroRNA Services Markets
| Mar 2009 |
£3,660 |
Technological Advances in Microscopy
| Mar 2009 |
£3,965 |
Wockhardt Limited-IT Sales Opportunities-2009
| Mar 2009 |
£610 |
Mayo Clinic Rochester-IT Sales Opportunities-2009
| Mar 2009 |
£610 |
Cardiac Biomarkers
| Feb 2009 |
£2,410 |
Freedonia Focus on Biotechnology: Pharmaceuticals
| Feb 2009 |
£310 |
Chinese Markets for Biopharmaceuticals
| Feb 2009 |
£2,440 |
North American Biolubricants Markets
| Feb 2009 |
£3,660 |
Top 10 Biotech Companies
Market Outlook, 2008-2023
| Jan 2009 |
£1,499 |
Understanding the Global Biotech Industry
The New 'Engine' of the Global Economy
| Jan 2009 |
£300 |
Commercial Amino Acids
| Jan 2009 |
£2,955 |
MarketWatch: Biotechnology
| Jan 2009 |
£120 |
Bioinformatics Market Potential
| Jan 2009 |
£300 |
Biophotonics: A Strategic Assessment of Photonics Technologies for Biomedical Applications
2nd Edition
| Dec 2008 |
£2,435 |
Strategic Analysis of Global Scientific Business Intelligence (Sci-BI) in Pharmaceutical and Biotechnology Markets
| Dec 2008 |
£3,660 |
U.S. MicroRNA Markets
| Dec 2008 |
£3,660 |
Strategic Analysis of the Energy Efficient Lamps Market in North America
| Dec 2008 |
£3,660 |
RNA Interference Markets
| Dec 2008 |
£2,105 |
Global Biotechnology Markets Trends
| Nov 2008 |
£360 |
Freedonia Focus on Biochip Products & Services
| Nov 2008 |
£310 |
Biopharmaceutical Expression Systems and Genetic Engineering Technologies
Current and Future Manufacturing Platforms
| Nov 2008 |
£400 |
Biotechnology: Global Industry Guide
| Nov 2008 |
£910 |
Stem Cells Come of Age
| Nov 2008 |
£2,285 |
Gene Therapy
| Oct 2008 |
£2,410 |
Biotechnology Reagents
| Oct 2008 |
£2,410 |
Biochips
| Oct 2008 |
£2,410 |
Gene Amplification Technologies
| Oct 2008 |
£2,410 |
Neurostimulation
| Oct 2008 |
£2,410 |
Mammography World Markets
| Oct 2008 |
£2,105 |
Hearing Aid Market Report: 2008 Edition
| Oct 2008 |
£545 |
Successful Pharmabiotech Alliance Strategies
Driving Synergies, Avoiding Failure and Managing Relationships
| Sep 2008 |
£2,340 |
Who's Developing What in Global Biopharmaceuticals?
Biopharmaceuticals, Pharmaceuticals, Healthcare, Company, Market
| Sep 2008 |
£695 |
Biosimilars: A viable market - but when?
| Sep 2008 |
£1,295 |
The Future of RNAi Therapeutics: Drug Pipelines and Prospects
| Sep 2008 |
£2,340 |
previous
